EyeMove Private
EyeMove is a program to reveal the initial stages of Parkinson's disease based on eye movemets. Early diagnosis of degenerative diseases of the central nervous system. If adequate methods of early diagnosis appear, this will allow the patient to continue his normal existence and his independence from others for a much longer period than even now using the existing methods of treatment.
Headquarters:
Moscow, Moscow City, Russian Federation
Investors Number:
2
Last Funding Type:
Seed
Funding Status:
Seed
Investor Type:
For Profit
Founded Date:
01.01.2016
Industry:
PharmTech
Technology:
Genetic Test & Molecular Diagnostics

